Coronavirus vaccine clinical trial of these drugs has also been approved


- Sponserd Ads -

The whole world is currently engaged in making the coronavirus vaccine. However, Italy and Israel have also claimed success in making the Corona vaccine.

The corona vaccine is being trialed by many countries. In the same sequence, clinical trials of two drugs Phevipirvir and Phytopharmaceutical have also been approved in the country.

CSIR receives approval for clinical trial of two drugs, ‘phytopharmaceutical & favipiravir’ to treat COVID-19

The Council for Scientific and Industrial Research (CSIR) has received approval for clinical trial of two drugs to treat COVID-19. The Drug Controller General of India (DGCI) has given approval for the clinical trials of the drugs namely, phytopharmaceutical and favipiravir.

CSIR Director-General, Shekhar Mande
CSIR Director-General, Shekhar Mande

CSIR Director-General, Shekhar Mande said that the drug trial will begin within a week. He also stated that CSIR has already been working with pharmaceutical companies for the solution to control COVID-19. Dr. Mande informed that Favipiravir is a proven anti influenza drug used in Japan, China, and other countries while Phytopharmaceutical is a herbal medicine extracted from plants.

According to Shekhar Mande, if the trial is successful, then the medicine for coronavirus will be available cheaply. Significantly, the number of corona infected people in India has now crossed 59 thousand. While this number has crossed four million in the world.

The Indian Telegraph
Established in 2007, The Indian Telegraph is a multi award winning digital media company based in Australia.

Share post:


More like this

Miss India Australia 2021 Winner

Sanya Arora, 22 years, dermal therapist, from Melbourne, has been...

Visa changes to support the reopening of Australia and our economic recovery

The Morrison Government is making it easier for highly...

Sydney international terminal bustling once again

After nearly 600 days of closed foreign borders, I...